Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches.
Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Influenza Vaccination market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Influenza Vaccination market. Detailed analysis of key players, along with key growth strategies adopted by Influenza Vaccination industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Hualan Biological Engineering Inc (Asia Pacific)
DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)
Sanofi (Europe)
GlaxoSmithKline plc (Europe)
BioCryst Pharmaceuticals, Inc (US)
Abbott (US)
F Hoffmann-La Roche Ltd (Europe)
Novartis AG (Europe)
Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
AstraZeneca (Europe)
By Type:
Egg Based
Cell Culture
Recombinant
By End-User:
Hospitals
Research Organizations
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Influenza Vaccination Market
-
1.3 Market Segment by Type
-
1.3.1 China Influenza Vaccination Market Size and Growth Rate of Egg Based from 2016 to 2027
-
1.3.2 China Influenza Vaccination Market Size and Growth Rate of Cell Culture from 2016 to 2027
-
1.3.3 China Influenza Vaccination Market Size and Growth Rate of Recombinant from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Influenza Vaccination Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 China Influenza Vaccination Market Size and Growth Rate of Research Organizations from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Influenza Vaccination Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Influenza Vaccination by Major Types
-
3.4.1 Market Size and Growth Rate of Egg Based
-
3.4.2 Market Size and Growth Rate of Cell Culture
-
3.4.3 Market Size and Growth Rate of Recombinant
4 Segmentation of Influenza Vaccination Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Influenza Vaccination by Major End-Users
-
4.4.1 Market Size and Growth Rate of Influenza Vaccination in Hospitals
-
4.4.2 Market Size and Growth Rate of Influenza Vaccination in Research Organizations
5 Market Analysis by Regions
-
5.1 China Influenza Vaccination Production Analysis by Regions
-
5.2 China Influenza Vaccination Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Influenza Vaccination Landscape Analysis
-
6.1 North China Influenza Vaccination Landscape Analysis by Major Types
-
6.2 North China Influenza Vaccination Landscape Analysis by Major End-Users
7 Central China Influenza Vaccination Landscape Analysis
-
7.1 Central China Influenza Vaccination Landscape Analysis by Major Types
-
7.2 Central China Influenza Vaccination Landscape Analysis by Major End-Users
8 South China Influenza Vaccination Landscape Analysis
-
8.1 South China Influenza Vaccination Landscape Analysis by Major Types
-
8.2 South China Influenza Vaccination Landscape Analysis by Major End-Users
9 East China Influenza Vaccination Landscape Analysis
-
9.1 East China Influenza Vaccination Landscape Analysis by Major Types
-
9.2 East China Influenza Vaccination Landscape Analysis by Major End-Users
10 Northeast China Influenza Vaccination Landscape Analysis
-
10.1 Northeast China Influenza Vaccination Landscape Analysis by Major Types
-
10.2 Northeast China Influenza Vaccination Landscape Analysis by Major End-Users
11 Southwest China Influenza Vaccination Landscape Analysis
-
11.1 Southwest China Influenza Vaccination Landscape Analysis by Major Types
-
11.2 Southwest China Influenza Vaccination Landscape Analysis by Major End-Users
12 Northwest China Influenza Vaccination Landscape Analysis
-
12.1 Northwest China Influenza Vaccination Landscape Analysis by Major Types
-
12.2 Northwest China Influenza Vaccination Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Hualan Biological Engineering Inc (Asia Pacific)
-
13.1.1 Hualan Biological Engineering Inc (Asia Pacific) Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)
-
13.2.1 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Sanofi (Europe)
-
13.3.1 Sanofi (Europe) Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 GlaxoSmithKline plc (Europe)
-
13.4.1 GlaxoSmithKline plc (Europe) Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 BioCryst Pharmaceuticals, Inc (US)
-
13.5.1 BioCryst Pharmaceuticals, Inc (US) Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Abbott (US)
-
13.6.1 Abbott (US) Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 F Hoffmann-La Roche Ltd (Europe)
-
13.7.1 F Hoffmann-La Roche Ltd (Europe) Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Novartis AG (Europe)
-
13.8.1 Novartis AG (Europe) Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
-
13.9.1 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 AstraZeneca (Europe)
-
13.10.1 AstraZeneca (Europe) Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Influenza Vaccination Market Size and Growth Rate of Egg Based from 2016 to 2027
-
Figure China Influenza Vaccination Market Size and Growth Rate of Cell Culture from 2016 to 2027
-
Figure China Influenza Vaccination Market Size and Growth Rate of Recombinant from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Influenza Vaccination Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Influenza Vaccination Market Size and Growth Rate of Research Organizations from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Influenza Vaccination Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Influenza Vaccination
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Influenza Vaccination by Different Types from 2016 to 2027
-
Table Consumption Share of Influenza Vaccination by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Egg Based
-
Figure Market Size and Growth Rate of Cell Culture
-
Figure Market Size and Growth Rate of Recombinant
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Influenza Vaccination by Different End-Users from 2016 to 2027
-
Table Consumption Share of Influenza Vaccination by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Research Organizations
-
Table China Influenza Vaccination Production by Regions
-
Table China Influenza Vaccination Production Share by Regions
-
Figure China Influenza Vaccination Production Share by Regions in 2016
-
Figure China Influenza Vaccination Production Share by Regions in 2021
-
Figure China Influenza Vaccination Production Share by Regions in 2027
-
Table China Influenza Vaccination Consumption by Regions
-
Table China Influenza Vaccination Consumption Share by Regions
-
Figure China Influenza Vaccination Consumption Share by Regions in 2016
-
Figure China Influenza Vaccination Consumption Share by Regions in 2021
-
Figure China Influenza Vaccination Consumption Share by Regions in 2027
-
Table North China Influenza Vaccination Consumption by Types from 2016 to 2027
-
Table North China Influenza Vaccination Consumption Share by Types from 2016 to 2027
-
Figure North China Influenza Vaccination Consumption Share by Types in 2016
-
Figure North China Influenza Vaccination Consumption Share by Types in 2021
-
Figure North China Influenza Vaccination Consumption Share by Types in 2027
-
Table North China Influenza Vaccination Consumption by End-Users from 2016 to 2027
-
Table North China Influenza Vaccination Consumption Share by End-Users from 2016 to 2027
-
Figure North China Influenza Vaccination Consumption Share by End-Users in 2016
-
Figure North China Influenza Vaccination Consumption Share by End-Users in 2021
-
Figure North China Influenza Vaccination Consumption Share by End-Users in 2027
-
Table Central China Influenza Vaccination Consumption by Types from 2016 to 2027
-
Table Central China Influenza Vaccination Consumption Share by Types from 2016 to 2027
-
Figure Central China Influenza Vaccination Consumption Share by Types in 2016
-
Figure Central China Influenza Vaccination Consumption Share by Types in 2021
-
Figure Central China Influenza Vaccination Consumption Share by Types in 2027
-
Table Central China Influenza Vaccination Consumption by End-Users from 2016 to 2027
-
Table Central China Influenza Vaccination Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Influenza Vaccination Consumption Share by End-Users in 2016
-
Figure Central China Influenza Vaccination Consumption Share by End-Users in 2021
-
Figure Central China Influenza Vaccination Consumption Share by End-Users in 2027
-
Table South China Influenza Vaccination Consumption by Types from 2016 to 2027
-
Table South China Influenza Vaccination Consumption Share by Types from 2016 to 2027
-
Figure South China Influenza Vaccination Consumption Share by Types in 2016
-
Figure South China Influenza Vaccination Consumption Share by Types in 2021
-
Figure South China Influenza Vaccination Consumption Share by Types in 2027
-
Table South China Influenza Vaccination Consumption by End-Users from 2016 to 2027
-
Table South China Influenza Vaccination Consumption Share by End-Users from 2016 to 2027
-
Figure South China Influenza Vaccination Consumption Share by End-Users in 2016
-
Figure South China Influenza Vaccination Consumption Share by End-Users in 2021
-
Figure South China Influenza Vaccination Consumption Share by End-Users in 2027
-
Table East China Influenza Vaccination Consumption by Types from 2016 to 2027
-
Table East China Influenza Vaccination Consumption Share by Types from 2016 to 2027
-
Figure East China Influenza Vaccination Consumption Share by Types in 2016
-
Figure East China Influenza Vaccination Consumption Share by Types in 2021
-
Figure East China Influenza Vaccination Consumption Share by Types in 2027
-
Table East China Influenza Vaccination Consumption by End-Users from 2016 to 2027
-
Table East China Influenza Vaccination Consumption Share by End-Users from 2016 to 2027
-
Figure East China Influenza Vaccination Consumption Share by End-Users in 2016
-
Figure East China Influenza Vaccination Consumption Share by End-Users in 2021
-
Figure East China Influenza Vaccination Consumption Share by End-Users in 2027
-
Table Northeast China Influenza Vaccination Consumption by Types from 2016 to 2027
-
Table Northeast China Influenza Vaccination Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Influenza Vaccination Consumption Share by Types in 2016
-
Figure Northeast China Influenza Vaccination Consumption Share by Types in 2021
-
Figure Northeast China Influenza Vaccination Consumption Share by Types in 2027
-
Table Northeast China Influenza Vaccination Consumption by End-Users from 2016 to 2027
-
Table Northeast China Influenza Vaccination Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Influenza Vaccination Consumption Share by End-Users in 2016
-
Figure Northeast China Influenza Vaccination Consumption Share by End-Users in 2021
-
Figure Northeast China Influenza Vaccination Consumption Share by End-Users in 2027
-
Table Southwest China Influenza Vaccination Consumption by Types from 2016 to 2027
-
Table Southwest China Influenza Vaccination Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Influenza Vaccination Consumption Share by Types in 2016
-
Figure Southwest China Influenza Vaccination Consumption Share by Types in 2021
-
Figure Southwest China Influenza Vaccination Consumption Share by Types in 2027
-
Table Southwest China Influenza Vaccination Consumption by End-Users from 2016 to 2027
-
Table Southwest China Influenza Vaccination Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Influenza Vaccination Consumption Share by End-Users in 2016
-
Figure Southwest China Influenza Vaccination Consumption Share by End-Users in 2021
-
Figure Southwest China Influenza Vaccination Consumption Share by End-Users in 2027
-
Table Northwest China Influenza Vaccination Consumption by Types from 2016 to 2027
-
Table Northwest China Influenza Vaccination Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Influenza Vaccination Consumption Share by Types in 2016
-
Figure Northwest China Influenza Vaccination Consumption Share by Types in 2021
-
Figure Northwest China Influenza Vaccination Consumption Share by Types in 2027
-
Table Northwest China Influenza Vaccination Consumption by End-Users from 2016 to 2027
-
Table Northwest China Influenza Vaccination Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Influenza Vaccination Consumption Share by End-Users in 2016
-
Figure Northwest China Influenza Vaccination Consumption Share by End-Users in 2021
-
Figure Northwest China Influenza Vaccination Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Hualan Biological Engineering Inc (Asia Pacific)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan Biological Engineering Inc (Asia Pacific)
-
Figure Sales and Growth Rate Analysis of Hualan Biological Engineering Inc (Asia Pacific)
-
Figure Revenue and Market Share Analysis of Hualan Biological Engineering Inc (Asia Pacific)
-
Table Product and Service Introduction of Hualan Biological Engineering Inc (Asia Pacific)
-
Table Company Profile and Development Status of DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)
-
Figure Sales and Growth Rate Analysis of DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)
-
Figure Revenue and Market Share Analysis of DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)
-
Table Product and Service Introduction of DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)
-
Table Company Profile and Development Status of Sanofi (Europe)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi (Europe)
-
Figure Sales and Growth Rate Analysis of Sanofi (Europe)
-
Figure Revenue and Market Share Analysis of Sanofi (Europe)
-
Table Product and Service Introduction of Sanofi (Europe)
-
Table Company Profile and Development Status of GlaxoSmithKline plc (Europe)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc (Europe)
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc (Europe)
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline plc (Europe)
-
Table Product and Service Introduction of GlaxoSmithKline plc (Europe)
-
Table Company Profile and Development Status of BioCryst Pharmaceuticals, Inc (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioCryst Pharmaceuticals, Inc (US)
-
Figure Sales and Growth Rate Analysis of BioCryst Pharmaceuticals, Inc (US)
-
Figure Revenue and Market Share Analysis of BioCryst Pharmaceuticals, Inc (US)
-
Table Product and Service Introduction of BioCryst Pharmaceuticals, Inc (US)
-
Table Company Profile and Development Status of Abbott (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott (US)
-
Figure Sales and Growth Rate Analysis of Abbott (US)
-
Figure Revenue and Market Share Analysis of Abbott (US)
-
Table Product and Service Introduction of Abbott (US)
-
Table Company Profile and Development Status of F Hoffmann-La Roche Ltd (Europe)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd (Europe)
-
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd (Europe)
-
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd (Europe)
-
Table Product and Service Introduction of F Hoffmann-La Roche Ltd (Europe)
-
Table Company Profile and Development Status of Novartis AG (Europe)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Europe)
-
Figure Sales and Growth Rate Analysis of Novartis AG (Europe)
-
Figure Revenue and Market Share Analysis of Novartis AG (Europe)
-
Table Product and Service Introduction of Novartis AG (Europe)
-
Table Company Profile and Development Status of Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
-
Figure Sales and Growth Rate Analysis of Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
-
Figure Revenue and Market Share Analysis of Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
-
Table Product and Service Introduction of Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
-
Table Company Profile and Development Status of AstraZeneca (Europe)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca (Europe)
-
Figure Sales and Growth Rate Analysis of AstraZeneca (Europe)
-
Figure Revenue and Market Share Analysis of AstraZeneca (Europe)
-
Table Product and Service Introduction of AstraZeneca (Europe)
-
